A HUMAN BRONCHIAL EPITHELIAL-CELL LINE RELEASES ARGININE-VASOPRESSIN - INVOLVEMENT OF CA2-ACTIVATED K+ CHANNELS()

Citation
J. Tamaoki et al., A HUMAN BRONCHIAL EPITHELIAL-CELL LINE RELEASES ARGININE-VASOPRESSIN - INVOLVEMENT OF CA2-ACTIVATED K+ CHANNELS(), Regulatory peptides, 74(2-3), 1998, pp. 91-95
Citations number
23
Categorie Soggetti
Endocrynology & Metabolism",Physiology
Journal title
ISSN journal
01670115
Volume
74
Issue
2-3
Year of publication
1998
Pages
91 - 95
Database
ISI
SICI code
0167-0115(1998)74:2-3<91:AHBELR>2.0.ZU;2-R
Abstract
To determine whether airway epithelium releases arginine vasopressin ( AVP) and, if so, what the mechanism of the release is, we studied cult ured human bronchial epithelial cell line, 16-HBE cells, in vitro. The cells spontaneously released small but significant amounts of AVP, an d this release was dose dependently increased by platelet-activating f actor (PAF) or bradykinin (BK). The PAF- and BK-induced AVP release wa s inhibited by 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate, a phosph olipase C inhibitor, and thapsigargin but not by Ca2+-free solution. P retreatment with the big conductance Ca2+-activated K+ channel blocker iberiotoxin attenuated the stimulated release of AVP, whereas apamin and glibenclamide were without effect. These results suggest that huma n bronchial epithelial cells release AVP and that the release may be s timulated by phospholipase C activation, mobilization of Ca2+ from int ernal stores and the concomitant activation of big conductance Ca2+-ac tivated K+ channels. (C) 1998 Elsevier Science B.V.